The Orange Pill Podcast

The Orange Pill Podcast

The Orange Pill Podcast 🎙️ Your go-to source for the latest in the dietary supplement and natural health product industry! Brought to you by KGK Science, a global leader in clinical research and regulatory consulting, this podcast delivers:

✔️ Breaking industry news and trends

✔️ Educational insights and practical takeaways

✔️ Discussions on cutting-edge research

✔️ Landmark cases and notable events shaping the field

Join us as we bridge the gap between science, regulation, and everyday impact!

Vitamin D has long been associated with bone health—but emerging neuroscience suggests its role goes far beyond that. In this episode, we explore how the so-called “sunshine vitamin” may influence brain structure, cognitive function, and long-term mental health outcomes. From its role as a neurosteroid regulating hundreds of genes to its connection with depression, ADHD, and dementia risk, the data is beginning to paint a much bigger picture. We also...
Anxiety is often framed as a psychological condition—but what if part of the story is biological? Emerging research in nutritional psychiatry is uncovering a consistent metabolic signature in individuals with anxiety: reduced levels of choline in the brain. In this episode, we explore the science behind this discovery, including: ✔ An 8% reduction in brain choline linked to anxiety ✔ The role of choline in brain structure, signaling, and resilience...
For decades, cardiovascular care has focused on slowing disease and not reversing it. But new clinical data is challenging that paradigm. In this episode, we break down emerging evidence showing that high-dose Nattokinase, a fibrinolytic enzyme derived from fermented soy, may do more than support heart health. It may actively reduce arterial plaque. From a 36% reduction in carotid plaque size to insights into autophagy, inflammation, and the gut-heart axis,...
100 episodes in and we’re tackling one of the most critical shifts in the industry. In Episode 100 of the Orange Pill Podcast, we break down recent FDA enforcement actions from CDER’s BIMO program that reveal a hard truth: Your supplement can become a drug- based on how you study it. From enrolling diseased populations without an IND to unethical consent practices and compromised data integrity, these cases highlight the...
What if the safety data behind a drug… couldn’t be verified? In Episode 99 of the Orange Pill Podcast, we break down a recent FDA Warning Letter that exposed a troubling “liaison” model, where a contract research company claimed ownership of studies it never actually conducted. From falsified study directors to missing raw data, this case reveals how gaps in oversight can compromise the very foundation of drug development, and...